Feb
28
Wed
CDH Workshop: Navigating Institutional Approval Guidelines @ LKSC Room 120
Feb 28 @ 4:00 pm – 5:00 pm
CDH Workshop: Navigating Institutional Approval Guidelines @ LKSC Room 120 | Palo Alto | California | United States

Are you interested in launching a mobile research study? Join us as Chief Privacy Officer Wendi Wright and Senior IRB Manager Maria Aldeguer share their knowledge on mobile medical apps, and ensure your project’s data is secure.

Wendi Wright is the Chief Privacy Officer. Prior to joining Stanford in April 2016, Wendi was Vice President/Chief Privacy and Security Counsel for Allscripts, a publicly traded healthcare IT Company. She has many years of experience in Legal, Privacy, Security and Compliance healthcare, public health, and emergency preparedness and bioterrorism.

Other leadership roles, including: Vice President/Chief Privacy & Security Counsel for Allscripts Healthcare, LLC, HIPAA Privacy & Security Officer/Compliance Officer for Abbott, Attorney/Chief Privacy Officer and Senior Policy Analyst, Bioterrorism and Emergency Preparedness for the City of Chicago Department of Public Health.

Wendi holds both a Master of Jurisprudence and a Juris Doctor from Loyola University School of Law (Chicago), and is CIPP certified for the US and the EU.

Maria Aldeguer is a Senior Institutional Review Board (IRB) Manager and has worked at the Research Compliance Office for ten years. She enjoys working with researchers and IRB Panel members on complicated issues dealing with how best to apply the regulations to rapidly advancing research. A native and energetic Texan, she loves to bake and teach Hot Pilates in her spare time.

RSVP here!

 

Sep
24
Tue
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center
Sep 24 – Sep 26 all-day
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center

The Canary Center at Stanford, founded in 2009 as the first research center in the world, entirely dedicated to cancer early detection, The Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, and Cancer Research UK, the largest independent funder of cancer research globally have formed an international collaboration to accelerate research in the early detection of cancer.

The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.

The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:

  • A lack of cohorts of sufficient size and a shortage of clinical samples available for research
  • Development and deployment of new technologies
  • Lack of understanding of the biology of early cancer and technologies to detect its features

2019 conference topic list includes:

  • Integrative Early Detection through multiple technologies
  • Prognostic Early Detection
  • Signals from beyond the tumor
  • Integrative Susceptibility for Early Detection
  • Fostering a translational mentality in Early Detection Research

CLICK HERE TO REGISTER.